Trial

Silexion Therapeutics Receives Approval from Israeli Ministry of Well being to Provoke Part 2/3 Scientific Trial of SIL204 in Regionally Superior Pancreatic Most cancers

March 25, 2026

Silexion Therapeutics Receives Approval from Israeli Ministry of Well being to Provoke Part 2/3 Scientific Trial of SIL204 in Regionally Superior Pancreatic Most cancers

March 19, 2026

Okoth Obado Verdict Nears as Kenya Awaits Ruling in Excessive-Profile Sharon Otieno Homicide Trial – Nairobi Wire